Asahi Life Asset Management Co., Ltd. Abb Vie Inc. Transaction History

Asahi Life Asset Management Co., Ltd.

$165 Million
Q3 2024

A detailed history of Asahi Life Asset Management Co., Ltd. transactions in Abb Vie Inc. stock. As of the latest transaction made, Asahi Life Asset Management Co., Ltd. holds 4,200 shares of ABBV stock, worth $772,380. This represents 0.5% of its overall portfolio holdings.

Number of Shares

4,200

Previous 5,450 22.94%

Holding current value

$772,380

Previous $934,000 11.24%

% of portfolio

0.5%

Previous 0.65%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	SELL	$163.84 - $199.33 $204,800 - $249,162	-1,250 Reduced 22.94%	4,200 $829,000
Q2 2024 Aug 06, 2024	BUY	$154.79 - $180.76 $534,025 - $623,622	3,450 Added 172.5%	5,450 $934,000
Q1 2024 May 03, 2024	SELL	$159.82 - $182.1 $617,704 - $703,816	-3,865 Reduced 65.9%	2,000 $364,000
Q4 2023 Feb 13, 2024	BUY	$137.6 - $154.97 $521,504 - $587,336	3,790 Added 182.65%	5,865 $908,000
Q3 2023 Nov 02, 2023	SELL	$133.59 - $154.65 $254,488 - $294,608	-1,905 Reduced 47.86%	2,075 $309,000
Q2 2023 Jul 21, 2023	SELL	$132.51 - $164.9 $267,670 - $333,098	-2,020 Reduced 33.67%	3,980 $536,000
Q1 2023 May 01, 2023	SELL	$144.61 - $166.54 $18,076 - $20,817	-125 Reduced 2.04%	6,000 $956,000
Q4 2022 Feb 10, 2023	SELL	$138.31 - $165.87 $37,343 - $44,784	-270 Reduced 4.22%	6,125 $990,000
Q3 2022 Nov 07, 2022	BUY	$134.21 - $153.93 $7,381 - $8,466	55 Added 0.87%	6,395 $858,000
Q2 2022 Aug 02, 2022	SELL	$137.62 - $174.96 $108,719 - $138,218	-790 Reduced 11.08%	6,340 $971,000
Q1 2022 May 11, 2022	SELL	$131.98 - $163.75 $95,025 - $117,900	-720 Reduced 9.17%	7,130 $1.16 Million
Q4 2021 Feb 02, 2022	SELL	$107.43 - $135.93 $6,445 - $8,155	-60 Reduced 0.76%	7,850 $1.06 Million
Q3 2021 Oct 29, 2021	SELL	$106.4 - $120.78 $7,448 - $8,454	-70 Reduced 0.88%	7,910 $853,000
Q2 2021 Aug 10, 2021	SELL	$105.21 - $117.21 $57,865 - $64,465	-550 Reduced 6.45%	7,980 $899,000
Q1 2021 May 07, 2021	BUY	$102.3 - $112.62 $590,271 - $649,817	5,770 Added 209.06%	8,530 $923,000
Q4 2020 Feb 12, 2021	SELL	$80.49 - $108.67 $144,077 - $194,519	-1,790 Reduced 39.34%	2,760 $296,000
Q3 2020 Nov 02, 2020	SELL	$85.91 - $100.83 $26,632 - $31,257	-310 Reduced 6.38%	4,550 $399,000
Q2 2020 Aug 05, 2020	BUY	$73.37 - $98.18 $232,582 - $311,230	3,170 Added 187.57%	4,860 $477,000
Q1 2020 May 15, 2020	SELL	$64.5 - $97.79 $502,455 - $761,784	-7,790 Reduced 82.17%	1,690 $129,000
Q4 2019 Feb 13, 2020	SELL	$72.13 - $90.25 $52,654 - $65,882	-730 Reduced 7.15%	9,480 $839,000
Q3 2019 Nov 13, 2019	BUY	$62.98 - $75.72 $88,801 - $106,765	1,410 Added 16.02%	10,210 $773,000
Q2 2019 Aug 09, 2019	BUY	$65.7 - $83.98 $409,968 - $524,035	6,240 Added 243.75%	8,800 $640,000
Q1 2019 May 07, 2019	SELL	$77.14 - $90.79 $668,803 - $787,149	-8,670 Reduced 77.2%	2,560 $206,000
Q4 2018 Feb 14, 2019	BUY	$77.85 - $96.01 $874,255 - $1.08 Million	11,230 New	11,230 $1.04 Million

Others Institutions Holding ABBV

# of Institutions

3,891

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $325B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Asahi Life Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Asahi Life Asset Management Co., Ltd. with notifications on news.

Account

Asahi Life Asset Management Co., Ltd. Abb Vie Inc. Transaction History